Back


09/01/2015
KURMA Partners invests in Orphazyme ApS
KURMA Partners invests in Orphazyme ApS, a leading European biopharmaceutical company developing Heat Shock Protein based treatment for lysosomal storage diseases and [...]

Download the pdf file





X

X